Literature DB >> 12429856

Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy.

Helen Vlassara1, Weijing Cai, Jill Crandall, Teresia Goldberg, Robert Oberstein, Veronique Dardaine, Melpomeni Peppa, Elliot J Rayfield.   

Abstract

Diet is a major environmental source of proinflammatory AGEs (heat-generated advanced glycation end products); its impact in humans remains unclear. We explored the effects of two equivalent diets, one regular (high AGE, H-AGE) and the other with 5-fold lower AGE (L-AGE) content on inflammatory mediators of 24 diabetic subjects: 11 in a 2-week crossover and 13 in a 6-week study. After 2 weeks on H-AGE, serum AGEs increased by 64.5% (P = 0.02) and on L-AGE decreased by 30% (P = 0.02). The mononuclear cell tumor necrosis factor-alphabeta-actin mRNA ratio was 1.4 +/- 0.5 on H-AGE and 0.9 +/- 0.5 on L-AGE (P = 0.05), whereas serum vascular adhesion molecule-1 was 1,108 +/- 429 and 698 +/- 347 ngml (P = 0.01) on L- and H-AGE, respectively. After 6 weeks, peripheral blood mononuclear cell tumor necrosis factor-alpha rose by 86.3% (P = 0.006) and declined by 20% (P, not significant) on H- or L-AGE diet, respectively; C-reactive protein increased by 35% on H-AGE and decreased by 20% on L-AGE (P = 0.014), and vascular adhesion molecule-1 declined by 20% on L-AGE (P < 0.01) and increased by 4% on H-AGE. Serum AGEs were increased by 28.2% on H-AGE (P = 0.06) and reduced by 40% on L-AGE (P = 0.02), whereas AGE low density lipoprotein was increased by 32% on H-AGE and reduced by 33% on L-AGE diet (P < 0.05). Thus in diabetes, environmental (dietary) AGEs promote inflammatory mediators, leading to tissue injury. Restriction of dietary AGEs suppresses these effects.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12429856      PMCID: PMC137762          DOI: 10.1073/pnas.242407999

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  46 in total

1.  von Willebrand factor, C-reactive protein, and 5-year mortality in diabetic and nondiabetic subjects: the Hoorn Study.

Authors:  A Jager; V W van Hinsbergh; P J Kostense; J J Emeis; J S Yudkin; G Nijpels; J M Dekker; R J Heine; L M Bouter; C D Stehouwer
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-12       Impact factor: 8.311

2.  Depletion of reactive advanced glycation endproducts from diabetic uremic sera using a lysozyme-linked matrix.

Authors:  T Mitsuhashi; Y M Li; S Fishbane; H Vlassara
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

3.  C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992.

Authors:  W Koenig; M Sund; M Fröhlich; H G Fischer; H Löwel; A Döring; W L Hutchinson; M B Pepys
Journal:  Circulation       Date:  1999-01-19       Impact factor: 29.690

4.  Increased levels of C-reactive protein in noncontrolled type II diabetic subjects.

Authors:  M Rodríguez-Morán; F Guerrero-Romero
Journal:  J Diabetes Complications       Date:  1999 Jul-Aug       Impact factor: 2.852

5.  Effect of oxidized lipids in the diet on oxidized lipid levels in postprandial serum chylomicrons of diabetic patients.

Authors:  I Staprans; D A Hardman; X M Pan; K R Feingold
Journal:  Diabetes Care       Date:  1999-02       Impact factor: 19.112

6.  Dietary glycotoxins: inhibition of reactive products by aminoguanidine facilitates renal clearance and reduces tissue sequestration.

Authors:  C He; J Sabol; T Mitsuhashi; H Vlassara
Journal:  Diabetes       Date:  1999-06       Impact factor: 9.461

Review 7.  Glycoxidation and lipoxidation in atherogenesis.

Authors:  J W Baynes; S R Thorpe
Journal:  Free Radic Biol Med       Date:  2000-06-15       Impact factor: 7.376

8.  Methylglyoxal modification of protein. Chemical and immunochemical characterization of methylglyoxal-arginine adducts.

Authors:  T Oya; N Hattori; Y Mizuno; S Miyata; S Maeda; T Osawa; K Uchida
Journal:  J Biol Chem       Date:  1999-06-25       Impact factor: 5.157

9.  Association of fibrinogen with cardiovascular risk factors and cardiovascular disease in the Framingham Offspring Population.

Authors:  J J Stec; H Silbershatz; G H Tofler; T H Matheney; P Sutherland; I Lipinska; J M Massaro; P F Wilson; J E Muller; R B D'Agostino
Journal:  Circulation       Date:  2000-10-03       Impact factor: 29.690

10.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

View more
  177 in total

1.  Serum concentration of an inflammatory glycotoxin, methylglyoxal, is associated with increased cognitive decline in elderly individuals.

Authors:  Michal Schnaider Beeri; Erin Moshier; James Schmeidler; James Godbold; Jaime Uribarri; Sarah Reddy; Mary Sano; Hillel T Grossman; Weijing Cai; Helen Vlassara; Jeremy M Silverman
Journal:  Mech Ageing Dev       Date:  2011-11-03       Impact factor: 5.432

Review 2.  Glycoxidation and diabetic complications: modern lessons and a warning?

Authors:  Helen Vlassara; Jaime Uribarri
Journal:  Rev Endocr Metab Disord       Date:  2004-08       Impact factor: 6.514

Review 3.  Hypertension in diabetes: the role of the vasculature.

Authors:  Naftali Stern; Yonit Marcus
Journal:  Curr Hypertens Rep       Date:  2004-04       Impact factor: 5.369

4.  Associations of processed meat and unprocessed red meat intake with incident diabetes: the Strong Heart Family Study.

Authors:  Amanda M Fretts; Barbara V Howard; Barbara McKnight; Glen E Duncan; Shirley A A Beresford; Mihriye Mete; Sigal Eilat-Adar; Ying Zhang; David S Siscovick
Journal:  Am J Clin Nutr       Date:  2012-01-25       Impact factor: 7.045

Review 5.  Targeting advanced glycation with pharmaceutical agents: where are we now?

Authors:  Danielle J Borg; Josephine M Forbes
Journal:  Glycoconj J       Date:  2016-07-09       Impact factor: 2.916

6.  Sweeteners and Risk of Obesity and Type 2 Diabetes: The Role of Sugar-Sweetened Beverages.

Authors:  Vasanti S Malik; Frank B Hu
Journal:  Curr Diab Rep       Date:  2012-01-31       Impact factor: 4.810

7.  Paradox of circulating advanced glycation end product concentrations in patients with congestive heart failure and after heart transplantation.

Authors:  A Heidland; K Sebeková; A Frangiosa; L S De Santo; M Cirillo; F Rossi; M Cotrufo; A Perna; A Klassen; R Schinzel; N G De Santo
Journal:  Heart       Date:  2004-11       Impact factor: 5.994

8.  Identifying advanced glycation end products as a major source of oxidants in aging: implications for the management and/or prevention of reduced renal function in elderly persons.

Authors:  Helen Vlassara; Jaime Uribarri; Luigi Ferrucci; Weijing Cai; Massimo Torreggiani; James B Post; Feng Zheng; Gary E Striker
Journal:  Semin Nephrol       Date:  2009-11       Impact factor: 5.299

9.  Increased serum levels of advanced glycation endproducts predict total, cardiovascular and coronary mortality in women with type 2 diabetes: a population-based 18 year follow-up study.

Authors:  B K Kilhovd; A Juutilainen; S Lehto; T Rönnemaa; P A Torjesen; K F Hanssen; M Laakso
Journal:  Diabetologia       Date:  2007-05-04       Impact factor: 10.122

10.  Advanced glycation end product receptor-1 transgenic mice are resistant to inflammation, oxidative stress, and post-injury intimal hyperplasia.

Authors:  Massimo Torreggiani; Huixian Liu; Jin Wu; Feng Zheng; Weijing Cai; Gary Striker; Helen Vlassara
Journal:  Am J Pathol       Date:  2009-09-24       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.